Clinical Trial Update: Drug-Drug Interaction Study With Rifampin [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study with rifampin in Alzheimer's disease has been completed, sponsored by Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED